Marcus Autism Center launches first-of-its-kind FDA-authorized device for early diagnosis of autism spectrum disorder
The EarliPoint device is a first-of-its-kind FDA-authorized tool for early diagnosis of autism spectrum disorder. Early detection can help jumpstart targeted treatment plans, improving outcomes for individuals with autism.
SourceChildren's Healthcare of Atlanta·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateSep 5, 2023